- Home
- NIVF vs NAOV Comparison
NIVF vs NAOV Comparison
Compare NIVF & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- NAOV
- Stock Information
- Founded
- NIVF 2011
- NAOV 2003
- Country
- NIVF Thailand
- NAOV United States
- Employees
- NIVF N/A
- NAOV N/A
- Industry
- NIVF
- NAOV Industrial Specialties
- Sector
- NIVF
- NAOV Health Care
- Exchange
- NIVF NYSE
- NAOV Nasdaq
- Market Cap
- NIVF 2.1M
- NAOV 2.4M
- IPO Year
- NIVF N/A
- NAOV N/A
- Fundamental
- Price
- NIVF $1.05
- NAOV $1.00
- Analyst Decision
- NIVF
- NAOV
- Analyst Count
- NIVF 0
- NAOV 0
- Target Price
- NIVF N/A
- NAOV N/A
- AVG Volume (30 Days)
- NIVF 9.1M
- NAOV 8.3M
- Earning Date
- NIVF 01-01-0001
- NAOV 08-13-2025
- Dividend Yield
- NIVF N/A
- NAOV N/A
- EPS Growth
- NIVF N/A
- NAOV N/A
- EPS
- NIVF N/A
- NAOV N/A
- Revenue
- NIVF $5,433,375.00
- NAOV $2,662,000.00
- Revenue This Year
- NIVF N/A
- NAOV N/A
- Revenue Next Year
- NIVF N/A
- NAOV N/A
- P/E Ratio
- NIVF N/A
- NAOV N/A
- Revenue Growth
- NIVF 5.79
- NAOV N/A
- 52 Week Low
- NIVF $1.00
- NAOV $0.67
- 52 Week High
- NIVF $656.00
- NAOV $16.25
- Technical
- Relative Strength Index (RSI)
- NIVF 33.99
- NAOV 34.30
- Support Level
- NIVF $1.00
- NAOV $0.88
- Resistance Level
- NIVF $6.13
- NAOV $0.94
- Average True Range (ATR)
- NIVF 0.17
- NAOV 0.12
- MACD
- NIVF -0.01
- NAOV 0.11
- Stochastic Oscillator
- NIVF 9.35
- NAOV 7.06
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.